MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
16.39
+0.13
+0.80%
Opening 13:22 12/29 EST
OPEN
17.00
PREV CLOSE
16.26
HIGH
17.50
LOW
16.26
VOLUME
597.62K
TURNOVER
--
52 WEEK HIGH
69.97
52 WEEK LOW
6.76
MARKET CAP
193.02M
P/E (TTM)
-0.8152
1D
5D
1M
3M
1Y
5Y
1D
Tonix Unveils Once-Yearly Lyme Prevention Antibody, Eyes FDA Talks In 2026
Benzinga · 1h ago
BUZZ-Tonix Pharmaceuticals ticks up after $20 million direct stock deal
Reuters · 5h ago
Tonix Pharma advances TNX-4800 Lyme disease program
TipRanks · 5h ago
TONIX PHARMACEUTICALS SHARES FALL 6.4% PREMARKET AFTER CO PRICES STOCK AND WARRANT OFFERING
Reuters · 5h ago
Tonix Pharmaceuticals announces pricing of $20M registered direct offering
Seeking Alpha · 5h ago
Tonix Sells 615,025 Shares at $16.26 Each in $20M Stock Deal With Point72
Benzinga · 5h ago
Tonix prices 615,025 shares at $16.26 in registered direct offering
TipRanks · 5h ago
Tonix Pharmaceuticals Announces $20 Million Offering With Pre-Funded Warrants
Reuters · 5h ago
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.